This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Insmed Incorporated. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Bastien Goegan: Innovator in DPP1 Inhibitors
Introduction
Bastien Goegan is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of reversible DPP1 inhibitors. His work is crucial for advancing treatments for diseases that can be managed through the administration of these inhibitors.
Latest Patents
Bastien Goegan holds a patent for "Reversible DPP1 inhibitors and uses thereof." This patent includes compounds of Formula (I), or pharmaceutically acceptable salts or deuterated forms thereof. The patent also details pharmaceutical compositions that comprise these compounds and methods for their use in treating diseases that are responsive to DPP1 inhibitors. He has 1 patent to his name.
Career Highlights
Bastien Goegan is currently associated with Insmed Incorporated, a company that focuses on innovative therapies for serious diseases. His role at Insmed has allowed him to contribute to the development of groundbreaking pharmaceutical solutions.
Collaborations
Bastien collaborates with Adrien Cerdan, who is also involved in the research and development of pharmaceutical innovations. Their partnership enhances the potential for creating effective treatments in their field.
Conclusion
Bastien Goegan's work in the realm of DPP1 inhibitors exemplifies the impact of innovative thinking in pharmaceuticals. His contributions are paving the way for new treatment options that can significantly improve patient outcomes.